Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05378919 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer

Study acronym: RECTUM2015
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 18, 2022 (before its estimated June 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Phase II, Multicenter, Open-label, Randomized Study evaluating neoadjuvant chemotherapy (FOLFOX4) in patients with stage II and III colorectal cancer with standard chemoradiation Defined by Magnetic Resonance Imaging
Trial Details
NCT Number NCT05378919
Lead Sponsor Lithuanian University of Health Sciences
Conditions
(from sponsor)		 Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX
Enrollment 250 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov